Joseph Larosa - Jun 24, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Stock symbol
REGN
Transactions as of
Jun 24, 2024
Transactions value $
-$3,721,049
Form type
4
Date filed
6/25/2024, 04:39 PM
Previous filing
Jun 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock +Options Exercise $8,029,432 +14,450 +39.66% $555.67 50,887 Jun 24, 2024 Direct
transaction REGN Common Stock -Tax liability -$11,750,481 -11,084 -21.78% $1,060.13 39,803 Jun 24, 2024 Direct
holding REGN Common Stock 371 Jun 24, 2024 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) -Options Exercise $0 -14,450 -50% $0.00 14,450 Jun 24, 2024 Common Stock 14,450 $555.67 Direct F1

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.